Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Diabetologia. 2010 May 1;53(8):1638–1646. doi: 10.1007/s00125-010-1763-3

Table 3.

Relation of Central Retinal Arteriole Equivalent and Central Retinal Venule Equivalent at Baseline to Change in Renal Endpoint Models.

Dependent Variable Independent Variable
Central retinal arteriole equivalent per SD
Central retinal venule equivalent per SD
Duration adjusted
Multivariatea adjusted
Duration adjusted
Multivariatea adjusted
Est (SE) P Est (SE) P Est (SE) P Est (SE) P
Change in glomerular filtration rate −0.52 (1.15) 0.65 0.08 (1.13) 0.94
Change in albumin excretion rate 0.04 (1.39) 0.97 0.09 (1.37) 0.95
Change in mesangial fractional volume/glomerulus 0.0051 (0.0033) 0.13 0.0042 (0.0033) 0.20
Change in mesangial matrix fractional volume/glomerulus 0.0045 (0.0022) 0.04 0.0032 (0.0022) 0.14 0.0046 (0.0021) 0.03 0.0033 (0.0021) 0.13
Change in mesangial cell fractional volume/glomerulus −0.0003 (0.0015) 0.86 0.0002 (0.0015) 0.89
Change in volume fraction of cortex which was interstitium −0.0032 (0.0044) 0.46 0.0040 (0.0043) 0.36
Change in volume fraction cortical tubules per total tubules which were atrophic −0.0012 (0.0036) 0.73 −0.0019 (0.0035) 0.58
Change in glomerular basement membrane width (nm) 9.30 (4.47) 0.04 7.29 (4.43) 0.10 8.06 (4.38) 0.07 5.03 (4.36) 0.25
Change in glomerulopathy index 1.38 (0.55) 0.01 1.06 (0.53) 0.05 1.27 (0.54) 0.02 0.81 (0.52) 0.12
a

From linear regression model.

b

Multivariate adjustment:

Change in glomerular basement membrane (GBM) width (nm): diabetes duration, glycosylated hemoglobin, sex.

Change in glomerulopathy index: diabetes duration, glycosylated hemoglobin, sex, drug trial treatment.

Change in peripheral GBM surface density/glomerulus: diabetes duration, glycosylated hemoglobin, study site.

Change in mesangial matrix fractional volume/glomerulus: diabetes duration, glycosylated hemoglobin.